From yesterdays announcement
A pilot clinical study has confirmed the BCAL technology can accurately discriminate between breast cancer positive and healthy controls and confirms its potential as an effective breast cancer screening tool. BCAL Dx is now moving from proof of concept to a larger clinical study to validate the accuracy and improve the scalability of the test.
So a clinical study will take place at some stage... Will make some inquires regarding the procedure to get into market.
Ann: Agreement to acquire BCAL Diagnostics-SPX.AX, page-11
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $47.56M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $55.74K | 5.574M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7380663 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 779553 | 3 |
View Market Depth
| Last trade - 15.57pm 26/11/2024 (20 minute delay) ? |
| SPX (ASX) Chart |
